State of Alaska, Department of Revenue

Position in PTGX — Protagonist Therapeutics, Inc

CIK 1370102 JUNEAU, AK

Position in PTGX

as of Jun 30, 2026 · filed Jul 20, 2026 Compact

Position Value

$3,442,536

-$472,757 QoQ

Shares Held

28,084

-24.4% QoQ

Ownership

0.043%

of shares outstanding

% of Portfolio

0.04%

of 13F equity value

Holder Rank

#115

of 341 holders

Holding Since

Sep 2024

8 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

State of Alaska, Department of Revenue holds $93,905,322 across 47 Biotechnology names. PTGX ranks #7 (3.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	31,836	$15,813,895
2	HALO	Halozyme Therapeutics, Inc.	142,422	$11,147,368
3	REGN	Regeneron Pharmaceuticals, Inc.	17,215	$10,734,240
4	JAZZ	Jazz Pharmaceuticals plc	38,357	$9,242,885
5	KRYS	Krystal Biotech, Inc.	13,385	$4,974,801
6	CORT	Corcept Therapeutics Inc	40,107	$3,487,302
7	PTGX	Protagonist Therapeutics, Inc This page	28,084	$3,442,536
8	TGTX	Tg Therapeutics, Inc.	62,402	$3,428,365

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,442,536	28,084	-24.4%	Shares	Sole	2026-07-20
2026-03-31	$3,915,293	37,147	-2.5%	Shares	Sole	2026-04-20
2025-12-31	$3,327,565	38,099	+29.5%	Shares	Sole	2026-01-23
2025-09-30	$1,954,702	29,425	-20.3%	Shares	Sole	2025-10-24
2025-06-30	$2,039,794	36,906	+11.8%	Shares	Sole	2025-07-16
2025-03-31	$1,596,992	33,023	-2.5%	Shares	Sole	2025-04-21
2024-12-31	$1,307,420	33,871	+0.8%	Shares	Sole	2025-01-27
2024-09-30	$1,512,675	33,615	—	Shares	Sole	2024-10-24
No filing history on record for this holder in this stock.